Company intelligence / Profile preview

Remedix Care

Ownership: Private
Development stage: Commercial

Overview

Remedix Care is Israel’s leading provider of sterile intravenous pharmaceutical preparations, including parenteral nutrition and outsourced chemotherapy compounding. The company supplies both hospitals and at-home patients with high-risk compounded medications. It was the first in Israel to manufacture IV nutrition solutions and remains a pioneer in this field. No clinical trial results apply as it does not develop proprietary therapeutics.

Therapeutic areas: GastroenterologyOncology
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Israeli hospitals

Beyond the preview

Go deeper on Remedix Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remedix Care.

Explore the full profile